Clinica Chimica Acta 1995: Vol 235 Index

7 Pages·1995·1 MB·English

Clinica Chimica Acta 235 (1995) 235-237
Author index
Volume 235 (1995)
Archbold, G.R., see McGrath, L.T. 235, 179 sponse. A study using acute pelvic inflamma-
Assogba, U., S. Lepage, E. Bruckert, D. tory disease as a model system 235, 71
Bonnefont-Rousselot, F. Dairou, J.L. de Chusney, G.D., M. Philippa, J.C. Pickup, Com-
Gennes, J. Delattre, Blood antioxidants (vita- parison of micro-enzymatic and high-perfor-
min E and §-carotene) in long-term low den- mance liquid chromatographic methods for
sity lipoprotein apheresis 235, 147 the assay of serum |,5-anhydroglucitol 235,
91
Barbier, Y., see Lafont, P. 235, 197 Clavey, V., see Médiéne, S. 235, 189
Bard, J.M., see Médiéne, S. 235, 189
Bardet, J., see Parvy, P. 235, | Dairou, F., see Assogba, U. 235, 147
Basu, P.S., S.K. Batabyal, A. Bhattacharya, T.K. Datta, T.K., see Basu, P.S. 235, 107
Datta, Cholinesterase activities in cerebro- de Gennes, J.L., see Assogba, U. 235, 147
spinal fluid of patients with idiopathic con- Delattre, J., see Assogba, U. 235, 147
vulsive disorders 235, 107 Desmet, G., see Castelain, S. 235, 81
Batabyal, S.K., see Basu, P.S. 235, 107 Dey, D.C., see Maekawa, M. 235, 41
Benhamamouch, S., see Médiéne, S. 235, 189 Diamandis, E.P., see Pace-Asciak, C.R. 235,
Bhattacharya, A., see Basu, P.S. 235, 107 207
Blaser, J., S. Triebel, H. Tschesche, A sandwich Doherty, C.C., see McGrath, L.T. 235, 179
enzyme immunoassay for the determination Donnell, G.N., see Xu, Y.-K. 235, 125
of neutrophil lipocalin in body fluids 235, Douglas, A.F., see McGrath, L.T. 235, 179
137
Bonnefont-Rousselot, D., see Assogba, U. 235, Etoh, K., see Maekawa, M. 235, 41
147
Bourbon, J., see Taieb, J. 235, 229 Fernandez-Romero, J.M., see Quiles, R. 235,
Brazier, M., see Castelain, S. 235, 81 169
Brihmer, C., see Christiansen, M. 235, 71 Figarella, C., see Lafont, P. 235, 197
Brown, J.H., see McGrath, L.T. 235, 179 Francoual, J., see Taieb, J. 235, 229
Bruckert, E., see Assogba, U. 235, 147 Frasion, C., see Taieb, J. 235, 229
Fruchart, J.C., see Médiéne, S. 235, 189
Calliauw, J., see Konings, C.H. 235, 101 Fukumoto, S., see Hata, K. 235, 221
Castelain, S., S. Kamel, C. Picard, G. Desmet, Furiya, K., see Yoshida, M. 235, 113
J.L. Sebert, M. Brazier, A simple and auto-
mated HPLC method for determination of Galvain, D., see Lafont, P. 235, 197
total hydroxyproline in urine. Comparison Goldberg, D.M., see Pace-Asciak, C.R. 235,
with excretion of pyridinolines 235, 81 207
Christiansen, M., C.K. Hegdall, C. Brihmer, Grainger, D.J., D.E. Mosedale, J.C. Metcalfe,
Alpha-fetoprotein and the acute phase re- P.L. Weissberg, P.R. Kemp, Active and acid-
0009-898 1/95/$09.50 © 1995 Elsevier Science B.V. All rights reserved
236 Author index / Clinica Chimica Acta 235 (1995) 235-237
activatable TGF-8 in human sera, platelets Archbold, Oxidative stress and erythrocyte
and plasma 235, || membrane fluidity in patients undergoing
Grillhofer, H., see Molinari, E.A. 235, 59 regular dialysis 235, 179
Guy-Crotte, O., see Lafont, P. 235, 197 Médiéne, S., S. Hakem, J.M. Bard, I. Medjaoui,
S. Benhamamouch, P. Lebel, J.C. Fruchart,
Hegdall, C.K., see Christiansen, M. 235, 71 V. Clavey, Serum lipoprotein profile in Alger-
Hahn, S., see Pace-Asciak, C.R. 235, 207 ian patients with celiac disease 235, 189
Hakem, S., see Médiéne, S. 235, 189 Medjaoui, I., see Médiéne, S. 235, 189
Hamada, T., see Niwa, T. 235, 33 Mertani, S., see Lafont, P. 235, 197
Hata, K., M. Miura, S. Fukumoto, T. Matsumoto, Messaoudi, C., see Taieb, J. 235, 229
Assay of serum pyridinoline: a potential marker Metcalfe, J.C., see Grainger, D.J. 235, 11
for bone resorption 235, 221 Miura, M., see Hata, K. 235, 221
Miyazaki, T., see Niwa, T. 235, 33
Ishikawa, J., see Maekawa, M. 235, 41 Molinari, E.A., P.F. Pichler, H. Grillhofer, G.M.
Izumi, M., see Maekawa, M. 235, 41 Kostner, Immunoturbidimetric determina-
tion of lipoprotein(a): improvement in the
Johnston, G.D., see McGrath, L.T. 235, 179 measurement of turbid and triglyceride-rich
samples 235, 59
Kamel, S., see Castelain, S. 235, 81 Mosedale, D.E., see Grainger, D.J. 235, 11
Kamoun, P., see Parvy, P. 235, | Mulder, C., see Konings, C.H. 235, 101
Kanno, T., see Maekawa, M. 235, 41 Mulder, K., see van Kamp, G.J. 235, 159
Kaufman, F.R., see Xu, Y.-K. 235, 125
Kemp, P.R., see Grainger, DJ. 235, 11 Ng, W.G., see Xu, Y.-K. 235, 125
Konings, C.H., M.A. Kuiper, C. Mulder, J. Niwa, T., K. Shiobara, T. Hamada, T. Miyazaki,
Calliauw, E.Ch. Wolters, CSF acetylcholin- S. Tsukushi, K. Uema, T. Tsuzuki, Serum
esterase in Parkinson disease: decreased pyridinolines as specific markers of bone re-
enzyme activity and immunoreactivity in de- sorption in hemodialyzed patients 235, 33
mented patients 235, 101
Kosaka, K., see Taketa, K. 235, 117 Pace-Asciak, C.R., S. Hahn, E.P. Diamandis, G.
Kostner, G.M., see Molinari, E.A. 235, 59 Soleas, D.M. Goldberg, The red wine
Kotani, K., see Maekawa, M. 235, 41 phenolics ¢rans-resveratrol and quercetin
Kuiper, M., see van Kamp, G.J. 235, 159 block human platelet aggregation and eico-
Kuiper, M.A., see Konings, C.H. 235, 101 sanoid synthesis: Implications for protection
against coronary heart disease 235, 207
Lafont, P., O. Guy-Crotte, C. Paulin, D. Galvain, Parvy, P., J. Bardet, D. Rabier, P. Kamoun, A
S. Mertani, C. Figarella, Y. Barbier, A speci- scheme for the interpretation of primary and
fic i radiometric assay of cationic secondary disturbances of plasma and
trypsin(ogen) that does not recognize trypsin- urinary amino acid profiles. A possible way
alpha-|-proteinase inhibitor complex 235, 197 to an expert system 235, |
Lebel, P., see Médiéne, S. 235, 189 Paulin, C., see Lafont, P. 235, 197
Lepage, S., see Assogba, U. 235, 147 Philippa, M., see Chusney, G.D. 235, 91
Lindenbaum, A., see Taieb, J. 235, 229 Picard, C., see Castelain, S. 235, 81
Luque de Castro, M.D., see Quiles, RR. 235, 169 Pichler, P.F., see Molinari, E.A. 235, 59
Pickup, J.C., see Chusney, G.D. 235, 91
Maekawa, M., K. Sudo, T. Kanno, K. Kotani,
D.C. Dey, J. Ishikawa, M. Izumi, K. Etoh, Quiles, R., J.M. Fernandez-Romero, M.D. Luque
Genetic basis of the silent phenotype of serum de Castro, Enzymatic determination of bicar-
butyrylcholinesterase in three compound bonate in serum by flow injection analy-
heterozygotes 235, 41 sis 235, 169
Magny, J.-F., see Taieb, J. 235, 229
Matsumoto, T., see Hata, K. 235, 221 Rabier, D., see Parvy, P. 235, |
McClean, E., see McGrath, L.T. 235, 179
McGrath, L.T., A.F. Douglas, E. McClean, J.H. Sebert, J.L., see Castelain, S. 235, 81
Brown, C.C. Doherty, G.D. Johnston, G.R. Shiobara, K., see Niwa, T. 235, 33
Author index / Clinica Chimica Acta 235 (1995) 235-237 237
Soleas, G., see Pace-Asciak, C.R. 235, 207 van Kamp, G.J., K. Mulder, M. Kuiper, E.Ch.
Sudo, K., see Maekawa, M. 235, 41 Wolters, Changed transferrin sialylation in
Parkinson's disease 235, 159
Taieb, J., J. Francoual, J.-F. Magny, C. Fraslon,
C. Messaoudi, A. Lindenbaum, J. Bourbon, Weissberg, P.L., see Grainger, DJ. 235, 11
Surfactant associated protein A determina- Wolters, E.Ch., see Konings, C.H. 235, 101
tion using a chemiluminescence system — Wolters, E.Ch., see van Kamp, G.J. 235, 159
application to tracheal aspirates from
newborns 235, 229 Xu, Y.-K., F.R. Kaufman, G.N. Donnell, W.G.
Takakuwa, Y., see Yoshida, M. 235, 113 Ng, Radiochemical assay of minute quantities
Taket, K., M. Ueda, K. Kosaka, Preferential of galactose-l-phosphate uridyltransferase
salivary-type hypoamylasemia in obesity 235, activity in erythrocytes and leukocytes of
117 galactosemia patients 235, 125
Triebel, S., see Blaser, J. 235, 137
Tschesche, H., see Blaser, J. 235, 137 Yoshida, M., K. Furiya, Y. Takakuwa, Urinary
Tsukushi, S., see Niwa, T. 235, 33 excretion of /N-acetyl-8-D-glucosaminidase
Tsuzuki, T., see Niwa, T. 235, 33 during normal pregnancy 235, 113
Ueda, M., see Taketa, K. 235, 117
Uema, K., see Niwa, T. 235, 33

ELSEVI Clinica Chimica Acta 235 (1995) 239-241
Subject index
Volume 235 (1995)
Acetylcholinesterase; Cerebrospinal fluid; Idio- failure; Free radicals; Membrane fluidity
pathic convulsive disorders; Infective and 235, 179
neoplastic diseases of CNS 235, 107 Apolipoproteins; Celiac disease; Lipoproteins
Acetylcholinesterase; Enzyme activity; Immuno- 235, 189
reactivity; Homospecific activity; Cerebro- Atherosclerosis; Lipoprotein(a); Lipemic sera;
spinal fluid; Parkinson's disease; Demented L-Proline; Turbidimetry 235, 59
Atherosclerosis; Thromboxane B,; Hepoxilins;
Anti-oxidants; Resveratrol; Quercetin 235,
Active TGF-8; Latent TGF-8; ELISAs; Human
serum; Human platelets; Human plasma
235, 11
Acute phase reaction; Alpha-fetoprotein; Pelvic
Bone resorption; Mpdeggeciion Pyridinolines;
inflammatory disease; Alpha-2-macroglo- Urine; High-performance liquid chromato-
bulin 235, 71
graphy 235, 81
Alkaline phosphatase; Pyridinoline; Hemodialy-
Bone resorption marker; Pyridinium crosslinks;
sis; Uremic serum; Parathyroid hormone; Pyridinoline; High performance liquid chro-
Osteocalcin 235, 33
matography 235, 221
Alpha-1-proteinase inhibitor-trypsin complex; [m-
Butyryicholinesterase; Genetic mutation; Silent
munoradiometric assay (IRMA); Monoclo-
gene; Compound heterozygote 235, 41
nal antibody; Immunoreactive trypsin(ogen);
Serum 235, 197
Alpha-2-macroglobulin; Alpha-fetoprotein; Acute B-Carotene; Low density lipoprotein apheresis;
phase reaction; Pelvic inflammatory disease Vitamin E; Serum; Lipoprotein 235, 147
235, 71 Celiac disease; Lipoproteins; Apolipoproteins
Alpha-fetoprotein; Acute phase reaction; Pelvic 235, 189
inflammatory disease; Alpha-2-macroglo- Cerebrospinal fluid; Acetyicholinesterase; En-
bulin 235, 71 zyme activity; Immunoreactivity; Homospeci-
Amino acids; Plasma; Urine; lon-exchange chro- fic activity; Parkinson's disease; Demented
matography; Ninhydrin detection 235, | patients 235, 101
Cerebrospinal fluid; Acetyicholinesterase; Idio-
pathic convulsive disorders; Infective and
neoplastic diseases of CNS 235, 107
Cerebrospinal fluid; Parkinson's disease; Trans-
B,; Hepoxilins; Resveratrol; Quercetin 235, ferrin; Sialylation; Iron transport 235, 159
207 Compound heterozygote; Butyryicholinesterase;
Antioxidants; Oxidative stress; Dialysis; Renal Genetic mutation; Silent gene 235, 41
0009-898 1/95/$09.50 © 1995 Elsevier Science B.V. All rights reserved
240 Subject index /C linica Chimica Acta 235 (1995) 239-241
Demented patients; Acetylcholinesterase; Enzyme Homospecific activity; Acetylcholinesterase;
activity; Immunoreactivity; Homospecific Enzyme activity; Immunoreactivity; Cerebro-
activity; Cerebrospinal fluid; Parkinson's spinal fluid; Parkinson's disease; Demented
disease 235, 101 patients 235, 101
Deoxyglucose; Anhydroglucitol; Diabetes melli- Human plasma; Active TGF-8; Latent TGF-8;
tus; High-performance liquid chromato- ELISAs; Human serum; Human platelets
graphy; Pyranose oxidase 235, 91 235, 11
Diabetes mellitus; Anhydroglucitol; Deoxyglu- Human platelets; Active TGF-8; Latent TGF-8;
cose; High-performance liquid chromatog- ELISAs; Human serum; Human plasma
raphy; Pyranose oxidase 235, 91 235, 11
Dialysis; Oxidative stress; Renal failure; Free Human serum; Active TGF-8; Latent TGF-8;
radicals; Antioxidants; Membrane fluidity ELISAs; Human platelets; Human plasma
235, 179 235, 11
Hyaline membrane disease; Surfactant protein-A;
ELISAs; Active TGF-8; Latent TGF-8; Human Tracheal aspirates; Neonate 235, 229
serum; Human platelets; Human plasma Hydroxyproline; Pyridinolines; Urine; High-
235, 11 performance liquid chromatography; Bone
Enzymatic; Bicarbonate; Flow injection analysis; resorption 235, 81
Stopped-flow; Serum 235, 169
Enzyme activity; Acetyicholinesterase; Immuno- Idiopathic convulsive disorders; Acetyicholineste-
reactivity; Homospecific activity; Cerebro- rase; Cerebrospinal fluid; Infective and neo-
spinal fluid; Parkinson's disease; Demented plastic diseases of CNS 235, 107
patients 235, 101 Immunoradiometric assay (IRMA); Monoclonal
antibody; Immunoreactive trypsin(ogen);
Flow injection analysis; Bicarbonate; Enzymatic; Serum; Alpha-|-proteinase inhibitor-trypsin
Stopped-flow; Serum 235, 169 complex 235, 197
Free radicals; Oxidative stress; Dialysis; Renal Immunoreactive trypsin(ogen); Immunoradio-
failure, Antioxidants; Membrane fluidity metric assay (IRMA); Monoclonal antibody;
235, 179 Serum; Alpha-1!-proteinase inhibitor-trypsin
complex 235, 197
Galact phosph uridyltransferase assay; Immunoreactivity; Acetylcholinesterase; Enzyme
Galactosemia; Galactosemia variants 235, activity; Homospecific activity; Cerebro-
125 spinal fluid; Parkinson's disease; Demented
Galactosemia; Galactosemia variants; Galactose- patients 235, 101
l-phosphate uridyltransferase assay 235, Infective and neoplastic diseases of CNS; Acetyl-
125 cholinesterase; Cerebrospinal fluid; Idio-
Galactosemia variants; Galactosemia; Galac- pathic convulsive disorders 235, 107
tose-l-phosphate uridyltransferase assay lon-exchange chromatography; Amino acids;
235, 125 Plasma; Urine; Ninhydrin detection 235, |
Genetic mutation; Butyryicholinesterase; Silent Iron transport; Parkinson's disease; Transferrin;
gene; Compound heterozygote 235, 41 Sialylation; Cerebrospinal fluid 235, 159
; Pyridinoline; Uremic serum; Para- Latent TGF-8; Active TGF-8; ELISAs; Human
thyroid hormone; Osteocalcin; Alkaline serum; Human platelets; Human plasma
phosphatase 235, 33 , 235, 11
Hepoxilins; Atherosclerosis; Thromboxane B); Lipemic sera; Lipoprotein(a); L-Proline; Turbi-
Anti-oxidants; Resveratrol; Quercetin 235, dimetry; Atherosclerosis 235, 59
207 Lipocalin; Neutrophils; Sandwich immunoassay
High performance liquid chromatography; Pyri- 235, 137
dinium crosslinks; Pyridinoline; Bone resorp- Lipoprotein; Low density lipoprotein apheresis;
tion marker 235, 221 Vitamin E; 8-Carotene; Serum 235, 147
High-performance liquid chromatography; Anhy- Lipoprotein(a); Lipemic sera; L-Proline; Turbi-
droglucitol; Deoxyglucose; Diabetes mellitus; dimetry; Atherosclerosis 235, 59
Lipoproteins; Celiac disease; Apolipoproteins
235, 189
droxyproline; Pyridinolines; Urine; Bone Low density lipoprotein apheresis; Vitamin E;
resorption 235, 81 8-Carotene; Serum; Lipoprotein 235, 147
Subject index / Clinica Chimica Acta 235 (1995) 239-241 241
Membrane fluidity; Oxidative stress; Dialysis; Quercetin; Atherosclerosis; Thromboxane B);
Renal failure; Free radicals; Antioxidants Hepoxilins; Anti-oxidants; Resveratrol 235,
235, 179 207
Monoclonal antibody. I radiometric assay
(IRMA), Immunoreactive trypsin(ogen); Renal failure; Oxidative stress; Dialysis; Free
Serum; Alpha-!-proteinase inhibitor-trypsin radicals; Antioxidants; Membrane fluidity
complex 235, 197 235, 179
Resveratrol; Atherosclerosis; Thromboxane B,;
Neonate; Surfactant protein-A; Tracheal aspi- Hepoxilins; Anti-oxidants; Quercetin 235,
rates; Hyaline membrane disease 235, 229 207
Neutrophils; Lipocalin; Sandwich immunoassay
235, 137 Salivary-type hypoamylasemia; Obesity 235,
Ninhydrin detection; Amino acids; Plasma; Urine; 117
lon-exchange chromatography 235, | Sandwich immunoassay; Lipocalin; Neutrophils
235, 137
Obesity; Salivary-type hypoamylasemia 235, Serum; Bicarbonate; Enzymatic; Flow injection
117 analysis; Stopped-flow 235, 169
Osteocalcin; Pyridinoline; Hemodialysis; Uremic Serum; Immunoradiometric assay (IRMA);
serum; Parathyroid hormone; Alkaline phos- Monoclonal antibody; Immunoreactive
phatase 235, 33 trypsin(ogen); Alpha-|-proteinase inhibitor-
Oxidative stress; Dialysis; Renal failure; Free trypsin complex 235, 197
radicals; Antioxidants; Membrane fluidity Serum; Low density lipoprotein apheresis; Vita-
235, 179 min E; 8-Carotene; Lipoprotein 235, 147
Sialylation; Parkinson’s disease; Transferrin;
Parathyroid hormone; Pyridinoline; Hemodialy- Cerebrospinal fluid; Iron transport 235, 159
sis; Uremic serum; Osteocalcin; Alkaline Silent gene; Butyryicholinesterase; Genetic muta-
phosphatase 235, 33 tion; Compound heterozygote 235, 41
Parkinson’s disease; Acetyicholinesterase; En- Stopped-flow; Bicarbonate; Enzymatic; Flow
zyme activity; Immunoreactivity; Homospeci- injection analysis; Serum 235, 169
fic activity; Cerebrospinal fluid; Demented Surfactant protein-A; Tracheal aspirates; Hyaline
patients 235, 101 membrane disease; Neonate 235, 229
Parkinson’s disease; Transferrin; Sialylation;
Cerebrospinal fluid; Iron transport 235, 159 Thromboxane B,; Atherosclerosis; Hepoxilins;
Pelvic inflammatory disease; Alpha-fetoprotein; Anti-oxidants; Resveratrol; Quercetin 235,
Acute phase reaction; Alpha-2-macroglobu- 207
lin 235, 71 Tracheal aspirates; Surfactant protein-A; Hyaline
Plasma; Amino acids; Urine; lon-exchange chro- membrane disease; Neonate 235, 229
matography; Ninhydrin detection 235, | Transferrin; Parkinson’s disease; Sialylation;
Pregnancy; N-Acetyl-8-D-glucosaminidase 235, Cerebrospinal fluid; Iron transport 235, 159
113 Turbidimetry; Lipoprotein(a); Lipemic sera;
L-Proline; Lipoprotein(a); Lipemic sera; Turbi- L-Proline; Atherosclerosis 235, 59
dimetry; Atherosclerosis 235, 59
Pyranose oxidase; Anhydroglucitol; Deoxyglu- Uremic serum; Pyridinoline; Hemodialysis; Para-
cose; Diabetes mellitus; High-performance thyroid hormone; Osteocalcin; Alkaline
liquid chromatography 235, 91 phosphatase 235, 33
Pyridinium crosslinks; Pyridinoline; Bone resorp- Urine; Amino acids; Plasma; lon-exchange chro-
tion marker; High performance liquid chro- matography; Ninhydrin detection 235, |
matography 235, 221 Urine; Hydroxyproline; Pyridinolines; High-
Pyridinoline; Hemodialysis; Uremic serum; Para- performance liquid chromatography; Bone
thyroid hormone; Osteocalcin; Alkaline resorption 235, 81
phosphatase 235, 33
Pyridinoline; Pyridinium crosslinks; Bone resorp- Vitamin E; Low density lipoprotein apheresis;
tion marker; High performance liquid chro- 8-CarSoerutm;e Linpoepro;tei n 235, 147
matography 235, 221
Pyridinolines; Hydroxyproline; Urine; High-
performance liquid chromatography; Bone
resorption 235, 81